Related Experiment Video
Updated: Oct 19, 2025

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Enroller Experience and Parental Familiarity of Disease Influence Participation in a Pediatric Trial
Jeff E Schunk1, Kammy K Jacobsen1, Dilon Stephens1
1University of Utah School of Medicine, Department of Pediatrics, Salt Lake City, Utah.
Insights
Parental consent for pediatric clinical trials is crucial. Familiarity with diabetic ketoacidosis (DKA) and enroller experience significantly increased parental permission rates in a DKA therapies study.
Area of Science:
- Pediatric clinical research
- Medical ethics in research
- Diabetology
Background:
- Parental consent is essential for pediatric clinical research, particularly in interventional studies.
- Understanding factors influencing consent is key to successful trial recruitment.
- This study focused on enrollment in a trial for therapies for diabetic ketoacidosis (DKA) in children.
Purpose of the Study:
- To investigate demographic, clinical, and environmental factors affecting parental permission for pediatric DKA research.
- To identify predictors of consent in interventional pediatric trials.
- To enhance recruitment strategies for pediatric clinical research.
Main Methods:
- Analysis of data from 250 patient/parent dyads approached for the PECARN FLUID trial.
- Utilized bivariable and multivariable analyses to assess factors influencing enrollment.
- Controlled for enroller characteristics in the statistical models.
Main Results:
- 71% of parents consented to their child's participation.
- Higher consent rates were observed for children with prior DKA episodes compared to new-onset diabetes.
- Enrollment was significantly more likely with experienced enrollers (OR 2.46).
Conclusions:
- Prior DKA history and enroller experience are significant positive predictors of parental consent.
- Factors like patient age, gender, insurance, and DKA severity did not influence participation likelihood.
- Findings can inform strategies to improve consent rates in pediatric DKA trials.
Introduction:
Acquiring parental consent is critical to pediatric clinical research, especially in interventional trials. In this study we investigated demographic, clinical, and environmental factors associated with likelihood of parental permission for enrollment in a study of therapies for diabetic ketoacidosis (DKA) in children.
Methods:
We analyzed data from patients and parents who were approached for enrollment in the Pediatric Emergency Care Applied Research Network (PECARN) Fluid Therapies Under Investigation in DKA (FLUID) trial at one major participating center. We determined the influence of various factors on patient enrollment, including gender, age, distance from home to hospital, insurance status, known vs new onset of diabetes, glycemic control (hemoglobin A1c), DKA severity, gender of the enroller, experience of the enroller, and time of enrollment. Patients whose parents consented to participate were compared to those who declined participation using bivariable and multivariable analyses controlling for the enroller.
Results:
A total of 250 patient/parent dyads were approached; 177 (71%) agreed to participate, and 73 (29%) declined. Parents of patients with previous episodes of DKA agreed to enroll more frequently than those with a first DKA episode (94.3% for patients with 1-2 previous DKA episodes, 92.3% for > 2 previous episodes, vs 64.9% for new onset diabetes and 63.2% previously diagnosed but no previous DKA). Participation was also more likely with more experienced enrollers (odds ratio [95% confidence interval] of participation for an enroller with more than two years' experience vs less than two years: 2.46 [1.53, 3.97]). After adjusting for demographic and clinical factors, significant associations between participation and both DKA history and enroller experience remained. Patient age, gender, distance of home from hospital, glycemic control, insurance status, and measures of DKA severity were not associated with likelihood of participation.
Conclusion:
Familiarity with the disease process (previously diagnosed diabetes and previous experience with DKA) and experience of the enroller favorably influenced the likelihood of parental permission for enrollment in a study of DKA in children.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmacokinetics in Pediatric Patients: Drug Metabolism

